CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −6,479 | $16.32 | $106K | 232,940 |
| 2026-02-17 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,305,379 |
| 2026-02-17 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $16.08 | $241K | 2,290,379 |
| 2026-02-17 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $16.08 | $96K | 2,284,379 |
| 2026-02-17 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 705,950 | ||
| 2026-02-09 | Grossman Jerrold B Director | Grant or award | +10,690 | 488,884 | ||
| 2026-02-09 | Grossman Jerrold B Director | Grant or award · Stock Option (Right to Buy) | +17,730 | 17,730 | ||
| 2026-02-09 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Grant or award | +91,631 | 580,321 | ||
| 2026-02-09 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Grant or award · Stock Option (right to buy) | +144,230 | 144,230 | ||
| 2026-02-09 | Grossman Adam S President and CEO | Grant or award | +282,529 | 2,290,379 | ||
| 2026-02-09 | Grossman Adam S President and CEO | Grant or award · Stock Option (right to buy) | +444,711 | 444,711 | ||
| 2026-02-09 | KWON YOUNG Director | Grant or award | +10,690 | 263,020 | ||
| 2026-02-09 | KWON YOUNG Director | Grant or award · Stock Option (Right to Buy) | +17,730 | 17,730 | ||
| 2026-02-09 | FINGER ALISON CECILY Director | Grant or award | +10,690 | 45,619 | ||
| 2026-02-09 | FINGER ALISON CECILY Director | Grant or award · Stock Option (Right to Buy) | +17,730 | 17,730 | ||
| 2026-02-09 | Salas Eduardo Rene Director | Grant or award | +10,690 | 21,579 | ||
| 2026-02-09 | Salas Eduardo Rene Director | Grant or award · Stock Option (Right to Buy) | +17,730 | 17,730 | ||
| 2026-02-09 | Guiheen Lawrence P. Director | Grant or award | +10,690 | 105,520 | ||
| 2026-02-09 | Guiheen Lawrence P. Director | Grant or award · Stock Option (Right to Buy) | +17,730 | 17,730 | ||
| 2026-02-09 | ELMS STEVE Director | Grant or award | +10,690 | 98,020 |
Page 3 of 31 · 618 trades